Sudeep Pharma Ltd vs Themis Medicare Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Jun 14, 2026

Key Highlights

The Latest Trading Price of Sudeep Pharma Ltd is ₹ 749.5 as of 12 Jun 15:30 . The P/E Ratio of Sudeep Pharma Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Themis Medicare Ltd changed from 7.2 on March 2021 to 45.3 on March 2025 . This represents a CAGR of 44.46% over 5 years The Market Cap of Sudeep Pharma Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of Themis Medicare Ltd changed from ₹ 257.55 crore on March 2021 to ₹ 1349 crore on March 2025 . This represents a CAGR of 39.28% over 5 years The revenue of Sudeep Pharma Ltd for the Mar '26 is ₹ 188.76 crore as compare to the Dec '25 revenue of ₹ 179.17 crore. This represent the growth of 5.35% The revenue of Themis Medicare Ltd for the Mar '26 is ₹ 87.13 crore as compare to the Dec '25 revenue of ₹ 96.93 crore. This represent the decline of -10.11% The ebitda of Sudeep Pharma Ltd for the Mar '26 is ₹ 69.02 crore as compare to the Dec '25 ebitda of ₹ 66.81 crore. This represent the growth of 3.31% The ebitda of Themis Medicare Ltd for the Mar '26 is ₹ 14.36 crore as compare to the Dec '25 ebitda of ₹ 15.73 crore. This represent the decline of -8.71% The net profit of Sudeep Pharma Ltd changed from ₹ 17.08 crore to ₹ 48.54 crore over 8 quarters. This represents a CAGR of 68.58% The net profit of Themis Medicare Ltd changed from ₹ 24.68 crore to ₹ 8.89 crore over 8 quarters. This represents a CAGR of -39.98% The Dividend Payout of Sudeep Pharma Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Themis Medicare Ltd changed from 14.84 % on March 2021 to 19.23 % on March 2025 . This represents a CAGR of 5.32% over 5 years .

About Sudeep Pharma Ltd

Sudeep Pharma Limited was incorporated as Sudeep Pharma Private Limited' as a private limited company dated December 21, 1989, issued by the Registrar of Companies, Ahmedabad.
Thereafter, Company was converted into a public limited company and the name of the Company was changed to Sudeep Pharma Limited' pursuant to fresh certificate of incorporation dated April 5, 1995, issued by the Assistant Registrar of Companies, Gujarat at Dadra & Nagar Haveli.
Company was subsequently converted back to a private limited company vide a fresh certificate of incorporation dated October 1, 2014 issued by the Assistant Registrar of Companies, Gujarat at Ahmedabad, and the name of Company was accordingly changed from Sudeep Pharma Limited' to Sudeep Pharma Private Limited'.
Further, Company was converted into a public limited company and consequently, the name of Company was changed to Sudeep Pharma Limited'.

About Themis Medicare Ltd

Themis Medicare Limited was formerly incorporated as 'Themis Chemicals Limited' in 1969.
The Company was originally promoted by Chemosyn and Medimpex but was taken over by a Group consisting of Shantibhai D Patel and K T Lakdawala who also have interests in Andhra Synthetics and Antibiotics, which was merged with Artemis Pharmaceuticals in April, 1993.
Thereafter, the name of the Company was changed to Themis Medicare Limited in 2001.
The Company is principally engaged in the business of manufacturing of finished formulations and synthetic Active Pharmaceutical Ingredients. In Mar.'95, the company came out with a public issue equity shares (premium : Rs 110) to finance the expansion-cum-modernisation of its synthetic bulk drug plant at Vapi, the setting up of a formulation unit at Lilora, Baroda as backward integration and to augment long-term working capital.

FAQs for the comparison of Sudeep Pharma Ltd and Themis Medicare Ltd

Which company has a larger market capitalization, Sudeep Pharma Ltd or Themis Medicare Ltd?

Market cap of Sudeep Pharma Ltd is 8,465 Cr while Market cap of Themis Medicare Ltd is 960 Cr

What are the key factors driving the stock performance of Sudeep Pharma Ltd and Themis Medicare Ltd?

The stock performance of Sudeep Pharma Ltd and Themis Medicare Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Sudeep Pharma Ltd and Themis Medicare Ltd?

As of June 14, 2026, the Sudeep Pharma Ltd stock price is INR ₹749.5. On the other hand, Themis Medicare Ltd stock price is INR ₹104.25.

How do dividend payouts of Sudeep Pharma Ltd and Themis Medicare Ltd compare?

To compare the dividend payouts of Sudeep Pharma Ltd and Themis Medicare Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.